Natco Pharma Ltd share price logo

Natco Pharma Ltd Share Price (NATCOPHARM)

₹873.050.01%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q1 '23 Results
Technicals
News and Events

Overview of Natco Pharma Ltd

Key events for Natco Pharma Ltd

  • Natco Pharma Leads Funding Round for Pee Safe - 12 Sep, 2023

    Natco Pharma Ltd has invested USD 3 million in a funding round for hygiene and wellness brand Pee Safe, out of the total round size of USD 6 million.

  • Natco Pharma Faces Antitrust Lawsuit in the US - 11 Sep, 2023

    Natco Pharma Ltd has been named as a defendant in an antitrust lawsuit filed by Louisiana Health Service & Indemnity Company and HMO Louisiana Inc. regarding Pomalidomide (Pomalyst), causing its shares to drop by 5.34%.

  • Natco Pharma Named in Antitrust Lawsuit - 09 Sep, 2023

    Natco Pharma, along with other drug makers, has been named as defendants in an antitrust lawsuit regarding a generic cancer treatment drug in the US. The company believes the matter is without merit.

  • Natco Pharma Named Defendant in Antitrust Lawsuit - 08 Sep, 2023

    Natco Pharma Ltd's involvement in an antitrust lawsuit regarding cancer drug Pomalidomide caused its share price to slump by over 3%.

  • Natco Pharma Invests $2 Million in ISCA Inc. - 31 Aug, 2023

    Natco Pharma Ltd has made a strategic investment of $2 million in Delaware-based ISCA Inc. for bio control of pests, acquiring a 5.79% stake.

  • Natco Pharma Declares Interim Dividend of Rs 7 per Share - 22 Aug, 2023

    Natco Pharma Ltd has announced an interim dividend of Rs 7 per equity share with a face value of Rs 2. The record date is August 22.

  • Krishna Institute of Medical Sciences and Natco Pharma among top bets in growing diagnostics sector - 21 Aug, 2023

    The organised companies' market share in the Indian diagnostics sector has increased from 15% to 17%. Krishna Institute of Medical Sciences and Natco Pharma are recommended as top picks.

  • Natco Pharma to Trade Ex-Dividend Soon - 17 Aug, 2023

    Natco Pharma Limited is set to trade ex-dividend in the next 4 days, with an upcoming dividend of ₹7.00 per share, increased from last year's total dividends per share of ₹5.50. The company paid out just 20% of its profit and 16% of its free cash flow last year, indicating a sustainable dividend.

  • Natco Pharma to Increase Dividend by 100% - 12 Aug, 2023

    Natco Pharma Limited has announced a 100% increase in its periodic dividend, taking the annual payment to 0.6% of the current stock price. The company's stock price has increased by 36% in the last three months, but the dividend yield is below industry standards. While earnings per share are forecasted to rise by 99.5%, investors should be cautious about the company's unstable dividend history.

  • Natco Pharma Ltd Exhibits Overbought Characteristics - 10 Aug, 2023

    According to ETMarkets, Natco Pharma Ltd is one of the 10 stocks exhibiting notable overbought characteristics based on their RSI values.

  • Natco Pharma Reports Strong Q1 Results - 09 Aug, 2023

    Natco Pharma Ltd reported a 31.2% rise in consolidated net profit at Rs 420.3 crore for Q1, and declared an interim dividend of Rs 7 per equity share of Rs 2 each for FY24. The stock also achieved a 52-week high of Rs 895.

  • Natco Pharma Shares Reach New High - 08 Aug, 2023

    Shares of Natco Pharma have reached a new 52-week high of Rs 879 and are trading above their IPO price.

  • Natco Pharma Stock Sees Gains and Overbought RSI - 31 Jul, 2023

    Natco Pharma Ltd's stock saw gains between 1-2%, while its RSI reached an overbought zone of 84.26 on July 28.

  • Natco Pharma Stock Shows Strength Amid Positive Momentum in Pharma Sector - 29 Jul, 2023

    The long-term chart of the Pharma sector indicates that it has bottomed out, and Natco Pharma's stock is showing signs of strength. It might be worth considering for long-term investors looking to take advantage of the positive momentum in the Pharma sector.

  • Natco Pharma Submits ANDA to FDA for Generic Version of Erdafitinib Tablets - 26 Jul, 2023

    Natco Pharma Ltd's shares reach a 52-week high of Rs 793.8 and the company submits an abbreviated new drug application (ANDA) to the US FDA for the generic version of Erdafitinib tablets.

  • Akash Bhanshali Acquires Stake in Natco Pharma - 25 Jul, 2023

    Natco Pharma Ltd's shares were trading in the red on the NSE after Akash Bhanshali acquired a 1% stake worth Rs 138 crore.

  • Natco Pharma's Net Cash Position Increases - 16 Jul, 2023

    Natco Pharma Ltd had a net cash position of ₹9.97b as of March 2023, with more cash than debt, indicating it can manage its debt safely.

  • Natco Pharma Shares Rise on Positive Sentiment and Strong Financial Performance - 26 Jun, 2023

    Natco Pharma Ltd's shares rose over 3% due to its robust product pipeline and strong positioning in catering to the growing demand for affordable healthcare. The company's financial performance was also strong with a 52% YoY increase in revenue and a consolidated net profit of Rs 275 crore.

  • Natco Pharma Ltd experiences strong breakout on daily and weekly charts - 25 Jun, 2023

    Natco Pharma Ltd recently had a strong breakout on the daily chart with high volumes, accompanied by a weekly breakout surpassing the previous five-week high. The momentum indicator RSI has shown a positive crossover, confirming a buy signal. The stock has support at 640 and potential targets for the upside are 750.

  • Natco Pharma Ltd exhibits bullish MACD crossover - 23 Jun, 2023

    Natco Pharma, a pharmaceutical company focused on generic drugs, has shown a bullish MACD crossover. With a strong product pipeline and track record, it is well-positioned to meet the growing demand for affordable healthcare solutions.

Analyst Rating for Natco Pharma Ltd stock

based on 13 analysts

HOLD
38.46%
Buy
38.46%
Hold
23.08%
Sell

Based on 13 analysts offering long term price targets for Natco Pharma Ltd. An average target of ₹790.38

Source: S&P Global Market Intelligence

Natco Pharma Ltd share Performance

  • ₹870.1
    ₹896.5
    ₹873.05
    downward going graph

    0.34%

    Downside

    Day's Volatility:3.02%

    Upside

    2.69%

    downward going graph
  • ₹502
    ₹928
    ₹873.05
    downward going graph

    42.50%

    Downside

    52 Weeks Volatility:48.79%

    Upside

    6.29%

    downward going graph
1 Month Return-2.46 %
3 Month Return25.93 %
1 Year Return42.05 %
Previous Close₹872.95
Open₹877.65
Volume4.17L
Market Cap₹15,635.40Cr

Natco Pharma Ltd Company Information

Natco Pharma Limited is an international, RD focused pharmaceutical company that specialises in the development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). Natco sells products in over 40 countries, and provides contract manufacturing services for other pharmaceutical companies. The company was originally founded in 1981, and has since enjoyed significant growth, launching a variety of products and earning a number of milestones such as a compulsory license from Bayer for its patent protected anticancer drug Nexavar in 2012, and various first-to-market generic drugs including HEPCINAT (generic Sofosbuvir) and Epclusa (a single tablet regimen for the treatment of genotypes 2 and 3 chronic hepatitis C virus HCV infection). In 2021, Natco had 8 launches in the domestic market and acquired Dash Pharmaceuticals LLC in the US. Natco has 8 international subsidiaries, including the Philippines, Australia, Brazil and the US, constantly achieving the first generic to market for a variety of drugs. Natco's ambition for growth looks set to continue in 2022, with a number of new launches planned.

Share Price: ₹873.05 per share as on 29 Sep, 2023 04:01 PM
Market Capitalisation: ₹15,635.40Cr as of today
Revenue: ₹926.90Cr as on March 2023 (Q1 23)
Net Profit: ₹275.80Cr as on March 2023 (Q1 23)
Listing date: 27 Dec, 1995
Chairperson Name: V C Nannapaneni
OrganisationNatco Pharma Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of Natco Pharma Ltd

Insights on Natco Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up
    img

    Mutual Funds have increased holdings from 8.50% to 9.45% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up
    img

    Retail Investor have increased holdings from 23.87% to 24.07% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    Price Rise
    img

    In the last 6 months, NATCOPHARM stock has moved up by 57.1%

  • imgPOSITIVE IMPACT

    Revenue Rich
    img

    Revenue is up for the last 3 quarters, 452.6 Cr → 926.9 Cr (in ₹), with an average increase of 28.2% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up
    img

    Promoters have increased holdings from 48.84% to 49.76% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    Profit Spike
    img

    Netprofit is up for the last 3 quarters, 56.8 Cr → 275.8 Cr (in ₹), with an average increase of 43.1% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year
    img

    In the last 1 year, NATCOPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Against Peers
    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 123.7% return, outperforming this stock by 132.3%

  • imgNEGATIVE IMPACT

    FII Holding Down
    img

    Foreign Institutions have decreased holdings from 11.91% to 11.02% in Jun 2023 quarter

Natco Pharma Ltd share Valuation

Natco Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (12.51x)

March 27, 2019

Today (19.45x)

September 28, 2023

Industry (47.79x)

September 28, 2023

Highest (90.32x)

April 6, 2022

LowHigh

Mutual Fund Holdings

Funds Holdings
Mirae Asset Emerging Bluechip Fund Direct Plan GrowthMirae Asset Emerging Bluechip Fund Direct Plan Growth0.88%
Mirae Asset Midcap Fund Direct GrowthMirae Asset Midcap Fund Direct Growth1.48%
Quant Small Cap Fund Growth Option Direct PlanQuant Small Cap Fund Growth Option Direct Plan2.02%
ICICI Prudential Value Discovery Fund Direct Plan GrowthICICI Prudential Value Discovery Fund Direct Plan Growth0.42%
ICICI Prudential India Opportunities Fund Direct GrowthICICI Prudential India Opportunities Fund Direct Growth0.9%

Natco Pharma Ltd Shareholding Pattern

InvestorsHoldings %Prev. 2 periods3M change
Promoter Holdings
49.76%
1.88
Foreign Institutions
11.02%
-7.48
Mutual Funds
9.45%
11.16
Retail Investors
24.07%
0.85
Others
5.7%
-17.10

Technicals of Natco Pharma Ltd share

News & Events of Natco Pharma Ltd

Frequently Asked Questions

Natco Pharma Ltd (NATCOPHARM) share price today is ₹873.05

  • Today’s highest price of Natco Pharma Ltd is ₹896.5.
  • Today’s lowest price of Natco Pharma Ltd is ₹870.1.

Today’s traded volume of Natco Pharma Ltd(NATCOPHARM) is 4.17L.

Today’s market capitalisation of Natco Pharma Ltd(NATCOPHARM) is ₹15635.4Cr.

Natco Pharma Ltd(NATCOPHARMPrice
52 Week High
₹928
52 Week Low
₹502

Natco Pharma Ltd(NATCOPHARM) share price is ₹873.05. It is down -5.92% from its 52 Week High price of ₹928

Natco Pharma Ltd(NATCOPHARM) share price is ₹873.05. It is up 73.91% from its 52 Week Low price of ₹502

Natco Pharma Ltd(NATCOPHARMReturns
1 Day Returns
0.1%
1 Month Returns
-2.46%
3 Month Returns
25.93%
1 Year Returns
42.05%